A5085321592- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Respiratory and Cough-Related Research
- Asthma and respiratory diseases
- Hemophilia Treatment and Research
- Inhalation and Respiratory Drug Delivery
- Glioma Diagnosis and Treatment
- Chemotherapy-related skin toxicity
- Urticaria and Related Conditions
- Autoimmune Bullous Skin Diseases
- Neuroblastoma Research and Treatments
- Cancer, Hypoxia, and Metabolism
- Colorectal Cancer Treatments and Studies
- Lung Cancer Diagnosis and Treatment
- Radiomics and Machine Learning in Medical Imaging
- Drug-Induced Adverse Reactions
- Pediatric health and respiratory diseases
- Chronic Obstructive Pulmonary Disease (COPD) Research
Hacettepe University
2025
Hacettepe University Hospital
2024
Başkent University Hospital
2022
Background: The data on subphenotypes and treatment responses to biologicals in late-onset asthma (LOA) is limited. This study aims compare the clinical characteristics severe patients receiving biological treatments, categorized into early-onset (EOA) LOA groups. Methods: Patients treated with omalizumab or mepolizumab for at least six months a tertiary care adult allergy clinic between December 2015 2023 were included. persistent respiratory symptoms starting age ≥40 years as LOA, while...
Non-steroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease (N-ERD) can be difficult to diagnose due the heterogeneity of phenotypes and a lack validated in vitro tests. This study aimed provide better understanding course N-ERD disease, analyze whether there was delay clinical diagnosis, explore factors that might cause diagnostic delay. observational, cross-sectional, included patients aged over 18. The time taken by clinicians recorded as clinician diagnosis time, while...
Introduction: Surgical interventions can trigger angioedema attacks in hereditary (HAE). The aim of this study was to assess the incidence perioperative and identify associated risk factors. Methods: This retrospective included HAE patients diagnosed between 1999 2024 at a tertiary adult allergy clinic. Data on surgical procedures were analyzed. Results: Of 102 patients, 28 excluded due incomplete data, leaving 74 (46 female, 62.2%). Fifty-three underwent 94 surgeries, with most common being...
Procarbazine is an oral chemotherapeutic agent used in the treatment of brain malignancies and associated with hypersensitivity reactions. In case grade 4 reactions, rechallenge should be avoided, replaced, unless curative, which application a desensitization protocol considered. We present successful procarbazine anaphylaxis.
To investigate the prognostic importance of pulmonary functions and their effect on survival in patients with operable non-small cell lung cancer (NSCLC), who underwent surgical resection and/or received medical treatment.Cohort study.University Health Sciences, Diskapi Training Research Hospital, Ankara, Turkey, between June 2013 March 2020.The study included a total 70 diagnosed comprising 35 treatment were treated medically. The effects age, gender, additional comorbidities, smoking...